Logo image of CHYM

CHIME FINANCIAL INC-CL A (CHYM) Stock Fundamental Analysis

NASDAQ:CHYM - US16935C1099 - Common Stock

24.64 USD
+0.33 (+1.36%)
Last: 9/4/2025, 8:00:01 PM
24.65 USD
+0.01 (+0.04%)
After Hours: 9/4/2025, 8:00:01 PM
Fundamental Rating

4

Overall CHYM gets a fundamental rating of 4 out of 10. We evaluated CHYM against 102 industry peers in the Financial Services industry. While CHYM has a great health rating, there are worries on its profitability. CHYM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CHYM has reported negative net income.
CHYM Yearly Net Income VS EBIT VS OCF VS FCFCHYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -100M -200M -300M -400M -500M

1.2 Ratios

The Return On Assets of CHYM (-1.33%) is worse than 82.35% of its industry peers.
CHYM's Return On Equity of -1.77% is on the low side compared to the rest of the industry. CHYM is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
ROA -1.33%
ROE -1.77%
ROIC N/A
ROA(3y)-16.76%
ROA(5y)N/A
ROE(3y)-22.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHYM Yearly ROA, ROE, ROICCHYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

CHYM has a better Gross Margin (87.60%) than 90.20% of its industry peers.
The Profit Margin and Operating Margin are not available for CHYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHYM Yearly Profit, Operating, Gross MarginsCHYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

CHYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
CHYM has about the same amout of shares outstanding than it did 1 year ago.
CHYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHYM Yearly Shares OutstandingCHYM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 100M 200M 300M
CHYM Yearly Total Debt VS Total AssetsCHYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 10.66 indicates that CHYM is not in any danger for bankruptcy at the moment.
CHYM's Altman-Z score of 10.66 is amongst the best of the industry. CHYM outperforms 92.16% of its industry peers.
CHYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.66
ROIC/WACCN/A
WACC8.86%
CHYM Yearly LT Debt VS Equity VS FCFCHYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 4.83 indicates that CHYM has no problem at all paying its short term obligations.
CHYM has a Current ratio of 4.83. This is amongst the best in the industry. CHYM outperforms 92.16% of its industry peers.
A Quick Ratio of 4.83 indicates that CHYM has no problem at all paying its short term obligations.
The Quick ratio of CHYM (4.83) is better than 92.16% of its industry peers.
Industry RankSector Rank
Current Ratio 4.83
Quick Ratio 4.83
CHYM Yearly Current Assets VS Current LiabilitesCHYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
The Revenue has grown by 30.88% in the past year. This is a very strong growth!
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)30.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CHYM will show a very strong growth in Earnings Per Share. The EPS will grow by 57.99% on average per year.
Based on estimates for the next years, CHYM will show a very strong growth in Revenue. The Revenue will grow by 22.03% on average per year.
EPS Next Y-5419.29%
EPS Next 2Y-49.02%
EPS Next 3Y57.99%
EPS Next 5YN/A
Revenue Next Year29.87%
Revenue Next 2Y25.16%
Revenue Next 3Y22.03%
Revenue Next 5YN/A

3.3 Evolution

CHYM Yearly Revenue VS EstimatesCHYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 1B 2B 3B
CHYM Yearly EPS VS EstimatesCHYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHYM. In the last year negative earnings were reported.
Also next year CHYM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHYM Price Earnings VS Forward Price EarningsCHYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHYM Per share dataCHYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CHYM's earnings are expected to grow with 57.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.02%
EPS Next 3Y57.99%

More info and screens

0

5. Dividend

5.1 Amount

CHYM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHIME FINANCIAL INC-CL A

NASDAQ:CHYM (9/4/2025, 8:00:01 PM)

After market: 24.65 +0.01 (+0.04%)

24.64

+0.33 (+1.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners31.98%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner Change-8.25%
Market Cap9.16B
Analysts80
Price Target39.47 (60.19%)
Short Float %1.43%
Short Ratio1.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.84%
PT rev (3m)N/A
EPS NQ rev (1m)22.16%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-12.06%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)4.44%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.79%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.47
P/FCF N/A
P/OCF N/A
P/B 6.41
P/tB 6.41
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.5
BVpS3.84
TBVpS3.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.33%
ROE -1.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.6%
FCFM N/A
ROA(3y)-16.76%
ROA(5y)N/A
ROE(3y)-22.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.83
Quick Ratio 4.83
Altman-Z 10.66
F-ScoreN/A
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)423.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-5419.29%
EPS Next 2Y-49.02%
EPS Next 3Y57.99%
EPS Next 5YN/A
Revenue 1Y (TTM)30.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year29.87%
Revenue Next 2Y25.16%
Revenue Next 3Y22.03%
Revenue Next 5YN/A
EBIT growth 1Y73.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year182.82%
EBIT Next 3Y101.44%
EBIT Next 5YN/A
FCF growth 1Y126.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.96%
OCF growth 3YN/A
OCF growth 5YN/A